Cargando…
Low serum iron as a possible risk factor for neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is a rare, but fatal condition characterized by rigidity, fever, dysautonomia and altered consciousness along with elevated serum creatinine phosphokinase levels and leukocytosis. Treatment of NMS includes symptomatic and specific treatment with drugs like bromoc...
Autores principales: | Patil, Bhushan Subhash, Subramanyam, Alka A, Singh, Shipra L, Kamath, Ravindra M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137635/ https://www.ncbi.nlm.nih.gov/pubmed/25143888 http://dx.doi.org/10.4103/2229-516X.136800 |
Ejemplares similares
-
Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003) -
NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997) -
Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016) -
Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023) -
Neuroleptic malignant syndrome: A diagnostic challenge
por: Ambulkar, Reshma P, et al.
Publicado: (2012)